ASF1B and thyroid gland papillary carcinoma: In addition, previous reports confirmed that miR-214-3p could inhibit the progression of multiple myeloma by targeting ASF1B (39), as well as being regulated by lncRNA SNHG3 to affect the development of papillary thyroid carcinoma (40).